LifeMD, Inc.
LFMD
$4.28
-$0.11-2.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.03% | -22.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.03% | -22.11% | |||
| Cost of Revenue | -1.66% | -18.66% | |||
| Gross Profit | 8.31% | -22.59% | |||
| SG&A Expenses | 30.82% | -24.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -6.42% | 14.35% | |||
| Total Operating Expenses | 23.20% | -22.81% | |||
| Operating Income | -713.44% | 44.26% | |||
| Income Before Tax | -726.43% | 68.31% | |||
| Income Tax Expenses | -- | -91.78% | |||
| Earnings from Continuing Operations | -715.87% | 69.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | 108.30% | |||
| Net Income | -144.44% | 624.52% | |||
| EBIT | -713.44% | 44.26% | |||
| EBITDA | -997.64% | 45.43% | |||
| EPS Basic | -149.68% | 513.09% | |||
| Normalized Basic EPS | -742.45% | 60.96% | |||
| EPS Diluted | -149.76% | 509.60% | |||
| Normalized Diluted EPS | -742.45% | 60.96% | |||
| Average Basic Shares Outstanding | 1.20% | 1.32% | |||
| Average Diluted Shares Outstanding | 1.20% | 1.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -3.25% | 1.19% | |||